Correlation Between Stereotaxis and Bionano Genomics
Can any of the company-specific risk be diversified away by investing in both Stereotaxis and Bionano Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stereotaxis and Bionano Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stereotaxis and Bionano Genomics, you can compare the effects of market volatilities on Stereotaxis and Bionano Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stereotaxis with a short position of Bionano Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stereotaxis and Bionano Genomics.
Diversification Opportunities for Stereotaxis and Bionano Genomics
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Stereotaxis and Bionano is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Stereotaxis and Bionano Genomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionano Genomics and Stereotaxis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stereotaxis are associated (or correlated) with Bionano Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionano Genomics has no effect on the direction of Stereotaxis i.e., Stereotaxis and Bionano Genomics go up and down completely randomly.
Pair Corralation between Stereotaxis and Bionano Genomics
Given the investment horizon of 90 days Stereotaxis is expected to generate 0.75 times more return on investment than Bionano Genomics. However, Stereotaxis is 1.34 times less risky than Bionano Genomics. It trades about 0.02 of its potential returns per unit of risk. Bionano Genomics is currently generating about -0.13 per unit of risk. If you would invest 220.00 in Stereotaxis on October 21, 2024 and sell it today you would lose (12.00) from holding Stereotaxis or give up 5.45% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Stereotaxis vs. Bionano Genomics
Performance |
Timeline |
Stereotaxis |
Bionano Genomics |
Stereotaxis and Bionano Genomics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Stereotaxis and Bionano Genomics
The main advantage of trading using opposite Stereotaxis and Bionano Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stereotaxis position performs unexpectedly, Bionano Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionano Genomics will offset losses from the drop in Bionano Genomics' long position.Stereotaxis vs. Accuray Incorporated | Stereotaxis vs. AngioDynamics | Stereotaxis vs. Cutera Inc | Stereotaxis vs. AtriCure |
Bionano Genomics vs. Intuitive Surgical | Bionano Genomics vs. Innovative Eyewear | Bionano Genomics vs. Stereotaxis | Bionano Genomics vs. Nexgel Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |